Maze Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -499 | -649 | -684 | |
EBITDA | -37,560 | -29,516 | -33,030 | -34,717 |
EBIT | -38,059 | -30,087 | -33,679 | -35,401 |
Net Income | -34,568 | -30,087 | -33,679 | -32,786 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,764 | -24,710 | -30,445 | -29,815 |
Cash | 189,247 | 316,773 | 264,541 | 294,374 |
Basic Shares | 42,976 | 45,779 | 43,850 | 43,797 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $167,500 | $0 | $0 |
Gross Profit | -2,403 | 167,500 | -4,089 | -3,820 |
EBITDA | -140,496 | 60,883 | -94,462 | -107,206 |
EBIT | -142,899 | 57,586 | -98,551 | -111,026 |
Net Income | -131,120 | 52,231 | -100,415 | -114,940 |
Net Change In Cash | 0 | 167,500 | 0 | 0 |
Free Cash Flow | -112,734 | 74,807 | -87,268 | -101,169 |
Cash | 189,247 | 196,812 | 29,158 | 99,919 |
Basic Shares | 42,976 | 43,796 | 43,776 | 43,776 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.65 |
2025-09-30 | -$0.66 |
2025-06-30 | -$0.77 |
2025-03-31 | -$1.15 |